TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9081682

Group type: EXPERIMENTAL
Intervention: High-fat diet with fish oil capsules (6 or 12 capsules daily)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Low-fat diet with fish
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: High-fat diet with fish
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 120
Study: 8256107

Group type: EXPERIMENTAL
Intervention: 250 mg salt weekly (n = 157)
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: 250 mg daily for 3 days followed by 250 mg weekly (n = 46)
Number of subjects: 359

Group type: COMPARATOR
Intervention: 300 mg weekly chloroquine (n = 156)
Number of subjects: 359
Study: 3698594

Group type: EXPERIMENTAL
Intervention: Contraceptive calendar
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Photo album
Number of subjects: 99

Group type: COMPARATOR
Intervention: General practice records
Number of subjects: 99
Study: 31214256

Group type: EXPERIMENTAL
Intervention: rTMS (5 sessions of bilateral 10 Hz rTMS over primary motor areas)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham stimulation (5 sessions of similar sham stimulation)
Number of subjects: 15
Study: 28076983

Group type: EXPERIMENTAL
Intervention: Multidimensional Family Therapy (MDFT)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Individual Psychotherapy (IP)
Number of subjects: 169
Study: 27614658

Group type: EXPERIMENTAL
Intervention: 50 mg of prednisone daily for 7 days
Number of subjects: 726

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 726
Study: 24632279

Group type: EXPERIMENTAL
Intervention: Drug-eluting stent (DES) treatment in patients with DM and type B2/C lesions
Number of subjects: 18441

Group type: COMPARATOR
Intervention: Drug-eluting stent (DES) treatment in patients without DM and type B2/C lesions
Number of subjects: 18441

Group type: EXPERIMENTAL
Intervention: Drug-eluting stent (DES) treatment in patients with DM and type A/B1 lesions
Number of subjects: 18441

Group type: COMPARATOR
Intervention: Drug-eluting stent (DES) treatment in patients without DM and type A/B1 lesions
Number of subjects: 18441

Group type: EXPERIMENTAL
Intervention: Cardiac death or myocardial infarction in patients with DM
Number of subjects: 18441

Group type: COMPARATOR
Intervention: Cardiac death or myocardial infarction in patients without DM
Number of subjects: 18441
Study: 22282543

Group type: EXPERIMENTAL
Intervention: Bupropion SR (300 mg, 150 mg once daily for 3 days then 150 mg twice daily)
Number of subjects: 540

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 540

Group type: EXPERIMENTAL
Intervention: Bupropion SR
Number of subjects: 540
Study: 20606533

Group type: EXPERIMENTAL
Intervention: HPV‐16/18 AS04‐adjuvanted vaccine
Number of subjects: 1040

Group type: COMPARATOR
Intervention: Hepatitis A vaccine
Number of subjects: 1040
Study: 17655704

Group type: EXPERIMENTAL
Intervention: Simvastatin administered during two cycles of treatment
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 6
Study: 15228063

Group type: EXPERIMENTAL
Intervention: Jellyfish sting inhibitor (Nidaria Technology Ltd, Jordan Valley, Israel)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional sunscreen
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Jellyfish sting inhibitor
Number of subjects: 24
Study: 12142558

Group type: EXPERIMENTAL
Intervention: IL-4, subcutaneous injection at a dose of 5 microg/kg/d, daily for 28 days followed by a 7-day rest period
Number of subjects: 49
Study: 9657628

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 216

Group type: COMPARATOR
Intervention: Felodipine
Number of subjects: 216
Study: 7644244

Group type: EXPERIMENTAL
Intervention: H-wave therapy (HWT) at various frequencies (2-60 Hz)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo (dummy power output)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 112
Study: 2507323

Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg q.p.m. or 40 mg q.p.m.)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Fenofibrate (200 mg bid)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Fenofibrate
Number of subjects: 16
Study: 752864

Group type: EXPERIMENTAL
Intervention: Weekly applications of BCG
Number of subjects: 55

Group type: COMPARATOR
Intervention: No further treatment (Control)
Number of subjects: 55
Study: 31529682

Group type: EXPERIMENTAL
Intervention: ACPA positive patients
Number of subjects: 53849

Group type: EXPERIMENTAL
Intervention: RF positive patients
Number of subjects: 53849

Group type: EXPERIMENTAL
Intervention: Higher ACPA titers
Number of subjects: 53849

Group type: EXPERIMENTAL
Intervention: Higher RF titers
Number of subjects: 53849

Group type: EXPERIMENTAL
Intervention: cDMARD-exposed patients
Number of subjects: 53849

Group type: EXPERIMENTAL
Intervention: bDMARD-exposed patients
Number of subjects: 53849
Study: 30801276

Group type: EXPERIMENTAL
Intervention: Pelvic rotation
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pelvic tilt
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Pelvic tilt (10° increase)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Pelvic rotation (± 20° of 65°)
Number of subjects: 8
Study: 28499555

Group type: EXPERIMENTAL
Intervention: Standing computer workstation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sitting computer workstation
Number of subjects: 20
Study: 26654907

Group type: EXPERIMENTAL
Intervention: Effervescent paracetamol
Number of subjects: 49

Group type: COMPARATOR
Intervention: Non-effervescent paracetamol
Number of subjects: 49
Study: 22842012

Group type: EXPERIMENTAL
Intervention: Multiple-choice question (MCQ) examination
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Physicians
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Senior physicians
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Participants with up-to-date PALS certification
Number of subjects: 435

Group type: EXPERIMENTAL
Intervention: Exploratory Factor Analysis (EFA)
Number of subjects: 435
Study: 21120542

Group type: EXPERIMENTAL
Intervention: Supreme(®) Laryngeal Mask
Number of subjects: 19

Group type: COMPARATOR
Intervention: Soft Seal(®) Laryngeal Mask
Number of subjects: 19
Study: 19487394

Group type: EXPERIMENTAL
Intervention: Foster care (removal from institutional care)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Care as usual (continued institutional care)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Institutional rearing (any history of institutional care)
Number of subjects: 136
Study: 17283316

Group type: EXPERIMENTAL
Intervention: Elective angioplasty with a balloon‐expandable stent (severe stenosis group)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Elective angioplasty with a balloon‐expandable stent (moderate stenosis group)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Severe stenosis group
Number of subjects: 213

Group type: COMPARATOR
Intervention: Moderate stenosis group
Number of subjects: 213
Study: 16115341

Group type: EXPERIMENTAL
Intervention: Daily antioxidant supplementation (120 mg vitamin C, 30 mg vitamin E, 6 mg beta-carotene, 100 microg Se, 20 mg Zn)
Number of subjects: 12741

Group type: EXPERIMENTAL
Intervention: Daily antioxidant supplementation
Number of subjects: 12741

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 12741

Group type: EXPERIMENTAL
Intervention: Baseline antioxidant status
Number of subjects: 12741
Study: 11805628

Group type: EXPERIMENTAL
Intervention: Transforaminal epidural steroid injections
Number of subjects: 48

Group type: COMPARATOR
Intervention: Saline trigger-point injections
Number of subjects: 48
Study: 10331891

Group type: EXPERIMENTAL
Intervention: Taping
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Swede-O
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: AirCast
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Active Ankle
Number of subjects: 14

Group type: COMPARATOR
Intervention: No stabilizer
Number of subjects: 14
Study: 8815273

Group type: EXPERIMENTAL
Intervention: Benazepril (10-20 mg once daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Captopril (50 mg 1-2 times daily)
Number of subjects: 30
Study: 2223740

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (1800 micrograms/d for more than 12 weeks)
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation along with iron
Number of subjects: 450

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 450
Study: 6993706

Group type: EXPERIMENTAL
Intervention: Single 3-g oral dose of amoxicillin trihydrate
Number of subjects: 134

Group type: COMPARATOR
Intervention: Conventional ten-day courses of sulfamethoxazole-trimethoprim
Number of subjects: 134

Group type: COMPARATOR
Intervention: Conventional ten-day courses of oral ampicillin sodium
Number of subjects: 134
Study: 30084992

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (nCT)
Number of subjects: 181

Group type: COMPARATOR
Intervention: Neoadjuvant chemoradiotherapy (nCRT)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Complete histological response (TRG 1)
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: No histological response (TRG 4)
Number of subjects: 181
Study: 27649778

Group type: EXPERIMENTAL
Intervention: 60 mg caffeine
Number of subjects: 82
Study: 25873248

Group type: EXPERIMENTAL
Intervention: Milnacipran
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 23381060

Group type: EXPERIMENTAL
Intervention: Radiation therapist-led psycho-educational intervention (two face-to-face consultations)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 122
Study: 22017968

Group type: EXPERIMENTAL
Intervention: Topical lidocaine (30 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 19193781

Group type: COMPARATOR
Intervention: 400 mg/day imatinib
Number of subjects: 1692

Group type: EXPERIMENTAL
Intervention: 800 mg/day imatinib
Number of subjects: 1692

Group type: EXPERIMENTAL
Intervention: 800 mg/day imatinib after crossover
Number of subjects: 1692

Group type: EXPERIMENTAL
Intervention: Both imatinib doses
Number of subjects: 1692
Study: 17972452

Group type: EXPERIMENTAL
Intervention: Autologous platelet gel (APG) and activated platelet-poor plasma (PPP) treatment
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 40
Study: 15458563

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 11598595

Group type: EXPERIMENTAL
Intervention: Exercise intervention (10-minute circuit of varied jumping activities, 3 times per week for 7 months)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 177
Study: 9562353

Group type: EXPERIMENTAL
Intervention: Insulin infusion at 40 mU x m(‐2) x min(‐1) with 20% glucose to maintain euglycaemia
Number of subjects: 10

Group type: COMPARATOR
Intervention: 0.9% NaCl infusion (control)
Number of subjects: 10
Study: 8005834

Group type: EXPERIMENTAL
Intervention: Enterococcus faecium and Bifidobacterium longum (6.4 x 10(8) cfu d‐1)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Lactobacillus acidophilus, Bif. bifidum, Lact. delbrueckii ssp. bulgaricus, and Streptococcus thermophilus (9 x 10(9) cfu d‐1)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo preparation
Number of subjects: 24
Study: 2509305

Group type: EXPERIMENTAL
Intervention: Acetic acid jelly (A)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Estrogen cream (B)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Fermented milk product (C)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Metronidazole (D)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 61
Study: 183788

Group type: EXPERIMENTAL
Intervention: LF 178 (200 to 400 mg daily for 1 to 18 months)
Number of subjects: 191
Study: 31121141

Group type: EXPERIMENTAL
Intervention: Minimally invasive radical hysterectomy
Number of subjects: 0
Study: 28502313

Group type: EXPERIMENTAL
Intervention: Klar bleiben program (intervention group)
Number of subjects: 4163

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 4163
Study: 25440329

Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg (group A)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg (group B)
Number of subjects: 240

Group type: COMPARATOR
Intervention: No atorvastatin (group C)
Number of subjects: 240
Study: 22107331

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV)
Number of subjects: 14
Study: 21921413

Group type: EXPERIMENTAL
Intervention: Rosuvastatin (2.5 mg/day increased to 10 mg/day)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Control (no rosuvastatin administered)
Number of subjects: 104
Study: 20070012

Group type: EXPERIMENTAL
Intervention: Comprehensive cultural competence curriculum
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 109
Study: 17039216

Group type: EXPERIMENTAL
Intervention: Pilates therapy
Number of subjects: 53

Group type: COMPARATOR
Intervention: Back School treatment
Number of subjects: 53
Study: 14736842

Group type: EXPERIMENTAL
Intervention: 5-HT(1A)R binding in PD patients
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 5-HT(1A)R binding in PD patients with comorbid depression
Number of subjects: 16

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 16
Study: 11529534

Group type: EXPERIMENTAL
Intervention: Intravenous sedation with midazolam
Number of subjects: 62

Group type: COMPARATOR
Intervention: Intranasal sedation with midazolam
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Biopsy procedure
Number of subjects: 62

Group type: COMPARATOR
Intervention: Comparison of sedation methods
Number of subjects: 62
Study: 9101306

Group type: EXPERIMENTAL
Intervention: ACE inhibitors (ceronapril or delapril)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Calcium antagonists (nifedipine or nicardipine)
Number of subjects: 33
Study: 8324671

Group type: EXPERIMENTAL
Intervention: Piperacillin
Number of subjects: 81

Group type: COMPARATOR
Intervention: Cefazolin
Number of subjects: 81
Study: 3717762

Group type: EXPERIMENTAL
Intervention: Supplemental oxygen therapy (PaO2, 69 +/- 4 mmHg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Room air breathing (PaO2, 43 +/- 3 mmHg)
Number of subjects: 10
Study: 31750018

Group type: EXPERIMENTAL
Intervention: Mixed-methods approach to characterize verbal expression of feelings
Number of subjects: 1

Group type: COMPARATOR
Intervention: Self-report checklists for emotional disorders (depression/anxiety)
Number of subjects: 1
Study: 27625052

Group type: EXPERIMENTAL
Intervention: Integrated EBM training
Number of subjects: 79

Group type: COMPARATOR
Intervention: Stand-alone EBM training
Number of subjects: 79
Study: 24425125

Group type: EXPERIMENTAL
Intervention: Clazosentan for the prevention of angiographic vasospasm
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Aneurysm-securing procedure, subarachnoid clot clearance, and intracerebral hemorrhage
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Markers of anemia and albumin levels
Number of subjects: 120
Study: 23363676

Group type: EXPERIMENTAL
Intervention: Management group (trained community hospital doctors)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (community doctors without special training)
Number of subjects: 200
Study: 18801830

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 70

Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 70
Study: 18061147

Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment (SSRI) for 12 weeks
Number of subjects: 18
Study: 15930193

Group type: EXPERIMENTAL
Intervention: Home-safety counseling including firearm safety
Number of subjects: 76
Study: 12805339

Group type: EXPERIMENTAL
Intervention: RSR13 plus cranial radiation therapy (30 Gy in 10 fractions of 3 Gy each), RSR13 dosage of 50 to 100 mg/kg intravenously over 30 minutes.
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: RSR13 plus cranial radiation therapy (30 Gy in 10 fractions of 3 Gy each).
Number of subjects: 57

Group type: COMPARATOR
Intervention: RTOG BMD patients (control group).
Number of subjects: 57
Study: 12409685

Group type: EXPERIMENTAL
Intervention: Antidepressants (imipramine, phenelzine, L-deprenyl, mianserin, desipramine)
Number of subjects: 940

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 940
Study: 9531406

Group type: EXPERIMENTAL
Intervention: Trunk deformity assessment using seven measures (shoulder-height difference, shoulder-angle asymmetry, decompensation, scapula asymmetry, waist crease, waist asymmetry, pelvic asymmetry)
Number of subjects: 20
Study: 7921519

Group type: EXPERIMENTAL
Intervention: 2.5 mg nicorandil
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 5 mg nicorandil
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 10 mg nicorandil
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 20 mg nicorandil
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: 30 mg nicorandil
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: All doses of nicorandil
Number of subjects: 42
Study: 3048155

Group type: EXPERIMENTAL
Intervention: Ticlopidine (250 mg, twice daily)
Number of subjects: 169

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 169
Study: 31708151

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose
Number of subjects: 2018

Group type: COMPARATOR
Intervention: Standard oral iron therapy
Number of subjects: 2018
Study: 29103436

Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) device used on one side of the maxillary arch for 7 hours on 3 consecutive nights.
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo PEMF device with inversely inserted battery used on the opposite side of the maxillary arch for 7 hours on 3 consecutive nights.
Number of subjects: 33
Study: 26614143

Group type: EXPERIMENTAL
Intervention: Injection dexmedetomidine 0.2 mcg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Injection lignocaine 0.2 mg/kg
Number of subjects: 60
Study: 22702490

Group type: EXPERIMENTAL
Intervention: Ferric citrate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21802079

Group type: EXPERIMENTAL
Intervention: Udenafil
Number of subjects: 278

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 278
Study: 19633278

Group type: EXPERIMENTAL
Intervention: Proactive telephone counseling (n = 769)
Number of subjects: 1562

Group type: COMPARATOR
Intervention: Self-help materials (control: n = 793)
Number of subjects: 1562

Group type: EXPERIMENTAL
Intervention: Proactive telephone counseling
Number of subjects: 1562

Group type: EXPERIMENTAL
Intervention: Active telephone recruitment
Number of subjects: 1562
Study: 16933433

Group type: EXPERIMENTAL
Intervention: Family therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study: 15129059

Group type: EXPERIMENTAL
Intervention: Functional restoration program
Number of subjects: 86

Group type: COMPARATOR
Intervention: Active individual therapy (3 hours physical therapy per week for 5 weeks)
Number of subjects: 86
Study: 11789860

Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 50
Study: 9437275

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 10000

Group type: EXPERIMENTAL
Intervention: Pravastatin (high risk subgroup)
Number of subjects: 10000
Study: 8270040

Group type: EXPERIMENTAL
Intervention: Initial test with >= 5 squares positive
Number of subjects: 137

Group type: COMPARATOR
Intervention: Initial test with < 5 squares positive
Number of subjects: 137
Study: 3560070

Group type: EXPERIMENTAL
Intervention: 12 mg metergoline
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 16 mg metergoline
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 5 mg bromoergocriptine
Number of subjects: 100

Group type: COMPARATOR
Intervention: metergoline treatment on the fourth postpartum day
Number of subjects: 100

Group type: COMPARATOR
Intervention: metergoline treatment on the eighth postpartum day
Number of subjects: 100

Group type: COMPARATOR
Intervention: metergoline treatment with TRH stimulation
Number of subjects: 100

Group type: COMPARATOR
Intervention: control group without metergoline treatment
Number of subjects: 100
Study: 30709725

Group type: EXPERIMENTAL
Intervention: Med-Jet® H4
Number of subjects: 80

Group type: COMPARATOR
Intervention: Needle injection
Number of subjects: 80
Study: 28651515

Group type: EXPERIMENTAL
Intervention: Adjunctive corticosteroid treatment
Number of subjects: 3800

Group type: EXPERIMENTAL
Intervention: Standard SAP for the ADRENAL trial
Number of subjects: 3800

Group type: EXPERIMENTAL
Intervention: Statistical comparisons between groups
Number of subjects: 3800
Study: 25928627

Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention including checklist, daily care goals, clinician prompting, and feedback on adherence rates.
Number of subjects: 118

Group type: COMPARATOR
Intervention: Usual care (Control group).
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Multifaceted quality improvement intervention.
Number of subjects: 118
Study: 24298765

Group type: EXPERIMENTAL
Intervention: Acupuncture at Jing-well points on the differentiated meridians and temple-three-needle therapy
Number of subjects: 73

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 73
Study: 20417055

Group type: EXPERIMENTAL
Intervention: Simulation (SIM) training
Number of subjects: 28

Group type: COMPARATOR
Intervention: Didactic lecture (LEC)
Number of subjects: 28
Study: 19909605

Group type: EXPERIMENTAL
Intervention: Piroxicam 10 mg oral dose 1-2 hours before embryo transfer
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no piroxicam)
Number of subjects: 200
Study: 16803675

Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factor
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 12953031

Group type: EXPERIMENTAL
Intervention: On-line convective treatments (HF and HDF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Low-flux HD
Number of subjects: 0